rs141292909

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2

The NM_014467.3(SRPX2):​c.1199A>G​(p.Asn400Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000196 in 1,020,097 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 4 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.000088 ( 0 hom., 0 hem., cov: 18)
Exomes 𝑓: 0.000013 ( 0 hom. 4 hem. )

Consequence

SRPX2
NM_014467.3 missense

Scores

17

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:1

Conservation

PhyloP100: 0.843

Publications

1 publications found
Variant links:
Genes affected
SRPX2 (HGNC:30668): (sushi repeat containing protein X-linked 2) This gene encodes a secreted protein that contains three sushi repeat motifs. The encoded protein may play a role in the development of speech and language centers in the brain. This protein may also be involved in angiogenesis. Mutations in this gene are the cause of bilateral perisylvian polymicrogyria, rolandic epilepsy, speech dyspraxia and cognitive disability. [provided by RefSeq, May 2010]
SRPX2 Gene-Disease associations (from GenCC):
  • rolandic epilepsy-speech dyspraxia syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • polymicrogyria, bilateral perisylvian, X-linked
    Inheritance: XL Classification: LIMITED Submitted by: G2P
  • rolandic epilepsy, intellectual disability, and speech dyspraxia, X-linked
    Inheritance: XL Classification: LIMITED, NO_KNOWN Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -9 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.02388984).
BP6
Variant X-100669351-A-G is Benign according to our data. Variant chrX-100669351-A-G is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 207384.
BS2
High AC in GnomAd4 at 8 XL,AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SRPX2NM_014467.3 linkc.1199A>G p.Asn400Ser missense_variant Exon 10 of 11 ENST00000373004.5 NP_055282.1 O60687

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SRPX2ENST00000373004.5 linkc.1199A>G p.Asn400Ser missense_variant Exon 10 of 11 1 NM_014467.3 ENSP00000362095.3 O60687
SRPX2ENST00000638920.1 linkn.1202A>G non_coding_transcript_exon_variant Exon 9 of 10 5
SRPX2ENST00000640282.1 linkc.142-1456A>G intron_variant Intron 2 of 2 5 ENSP00000491188.1 A0A1W2PNZ6

Frequencies

GnomAD3 genomes
AF:
0.0000884
AC:
8
AN:
90512
Hom.:
0
Cov.:
18
show subpopulations
Gnomad AFR
AF:
0.000287
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000212
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000234
AC:
4
AN:
170754
AF XY:
0.00
show subpopulations
Gnomad AFR exome
AF:
0.000241
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000134
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000129
AC:
12
AN:
929585
Hom.:
0
Cov.:
31
AF XY:
0.0000132
AC XY:
4
AN XY:
303159
show subpopulations
African (AFR)
AF:
0.000231
AC:
5
AN:
21689
American (AMR)
AF:
0.00
AC:
0
AN:
29566
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
13432
East Asian (EAS)
AF:
0.00
AC:
0
AN:
14197
South Asian (SAS)
AF:
0.0000193
AC:
1
AN:
51741
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
25714
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
3110
European-Non Finnish (NFE)
AF:
0.00000680
AC:
5
AN:
735361
Other (OTH)
AF:
0.0000288
AC:
1
AN:
34775
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.431
Heterozygous variant carriers
0
1
2
2
3
4
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000884
AC:
8
AN:
90512
Hom.:
0
Cov.:
18
AF XY:
0.00
AC XY:
0
AN XY:
20302
show subpopulations
African (AFR)
AF:
0.000287
AC:
7
AN:
24428
American (AMR)
AF:
0.00
AC:
0
AN:
7537
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2346
East Asian (EAS)
AF:
0.00
AC:
0
AN:
2342
South Asian (SAS)
AF:
0.00
AC:
0
AN:
1325
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
3462
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
186
European-Non Finnish (NFE)
AF:
0.0000212
AC:
1
AN:
47073
Other (OTH)
AF:
0.00
AC:
0
AN:
1203
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.519
Heterozygous variant carriers
0
1
2
3
4
5
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0000434
Hom.:
0
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000297
AC:
2
ExAC
AF:
0.0000248
AC:
3

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Rolandic epilepsy, intellectual disability, and speech dyspraxia, X-linked Uncertain:1
Aug 22, 2022
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This sequence change replaces asparagine, which is neutral and polar, with serine, which is neutral and polar, at codon 400 of the SRPX2 protein (p.Asn400Ser). This variant is present in population databases (rs141292909, gnomAD 0.03%). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Tolerated"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0". The serine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. ClinVar contains an entry for this variant (Variation ID: 207384). This variant has not been reported in the literature in individuals affected with SRPX2-related conditions. -

not provided Benign:1
Nov 13, 2018
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.062
BayesDel_addAF
Benign
-0.55
T
BayesDel_noAF
Benign
-1.0
CADD
Benign
13
DANN
Benign
0.81
DEOGEN2
Benign
0.042
T
FATHMM_MKL
Benign
0.076
N
LIST_S2
Benign
0.67
T
M_CAP
Benign
0.0076
T
MetaRNN
Benign
0.024
T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
-0.90
N
PhyloP100
0.84
PrimateAI
Benign
0.32
T
PROVEAN
Benign
0.40
N
REVEL
Benign
0.050
Sift
Benign
0.59
T
Sift4G
Benign
0.66
T
Polyphen
0.0
B
Vest4
0.097
MVP
0.26
MPC
0.12
ClinPred
0.0030
T
GERP RS
-2.5
Varity_R
0.031
gMVP
0.11
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.030
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs141292909; hg19: chrX-99924348; API